Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -13.41
- Piotroski Score 2.00
- Grade Buy
- Symbol (CARM)
- Company Carisma Therapeutics, Inc.
- Price $0.88
- Changes Percentage (-0.93%)
- Change -$0.01
- Day Low $0.87
- Day High $0.91
- Year High $3.16
Carisma Therapeutics, Inc., a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors. Its solutions are used to play a crucial role in the innate and adaptive immune response, and technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy for the treatment of human diseases. Carisma Therapeutics, Inc. has a strategic collaboration agreement with Moderna Inc. Carisma Therapeutics, Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was incorporated in 2016 and is based in Philadelphia, Pennsylvania.
- Last Earnings 02/03/2023
- Ex-Dividend for 5/16 Dividend 03/08/2023
- Dividend Payable 03/08/2023
- Today N/A
- Next Earnings (Estimated) 04/07/2025
- Fiscal Year End N/A
- Average Stock Price Target $6.00
- High Stock Price Target $6.00
- Low Stock Price Target $6.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.12
- Trailing P/E Ratio -0.96
- Forward P/E Ratio -0.96
- P/E Growth -0.96
- Net Income $-86,879,000
Income Statement
Quarterly
Annual
Latest News of CARM
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Carmelo Anthony's Son Kiyan Commits to Dad's Alma Mater Syracuse: 'I Want to Go in There and Create My Own Name'
Bailey Richards, a writer-reporter at PEOPLE since 2023, previously contributed to digital publications like Paper Magazine. Carmelo Anthony's son, Kiyan, a top basketball recruit, has chosen to atten...
By PEOPLE.com | 2 days ago -
Kiyan Anthony, son of Carmelo, makes his Syracuse-USC commitment...
Kiyan Anthony, son of Carmelo Anthony, commits to play basketball for Syracuse University next year, following his father's footsteps. The 4-star recruit is set to join the Orange's impressive Class o...
By New York Post | 3 days ago -
Kiyan Anthony, son of Carmelo Anthony, commits to Syracuse: What 4-star brings to Orange
Kiyan Anthony, a four-star guard and son of NBA star Carmelo Anthony, has committed to Syracuse over USC and Auburn. He follows in his father's footsteps, aiming to make a mark in NCAA basketball like...
By The New York Times | 3 days ago
